MERILEE RAINES Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MERILEE RAINES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MERILEE RAINES. MERILEE RAINES is Corporate VP & CFO in IDEXX LABORATORIES INC /DE ($IDXX) and Executive VP & CFO in IDEXX LABORATORIES INC /DE ($IDXX) and Vice President CFO & Treasurer in IDEXX LABORATORIES INC /DE ($IDXX) and Vice President,CFO & Treasurer in IDEXX LABORATORIES INC /DE ($IDXX) and VP & Chief Financial Officer in IDEXX LABORATORIES INC /DE ($IDXX) and Director in WATTS WATER TECHNOLOGIES INC ($WTS) and Director in AFFYMETRIX INC ($AFFX) and Director in BENCHMARK ELECTRONICS INC ($BHE) and Director in ARATANA THERAPEUTICS, INC. ($PETX).
Latest Insider Trading Transactions of MERILEE RAINES
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFFX, PETX, BHE, IDXX, WTS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | BHE | BENCHMARK ELECTRON ... | RAINES MERILEE | Director | Grant | A | 0.00 | 5,200 | 0 | 24,489 | 19.3 K to 24.5 K (+26.96 %) |
| Jul 27 2020 | WTS | WATTS WATER TECHNO ... | RAINES MERILEE | Director | Grant | A | 0.00 | 1,359 | 0 | 17,494 | 16.1 K to 17.5 K (+8.42 %) |
| May 14 2020 | BHE | BENCHMARK ELECTRON ... | RAINES MERILEE | Director | Grant | A | 0.00 | 7,883 | 0 | 19,289 | 11.4 K to 19.3 K (+69.11 %) |
| Jul 30 2019 | WTS | WATTS WATER TECHNO ... | RAINES MERILEE | Director | Grant | A | 0.00 | 1,381 | 0 | 16,135 | 14.8 K to 16.1 K (+9.36 %) |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 4.80 | 7,500 | 36,000 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 4.36 | 7,500 | 32,700 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 6.84 | 7,500 | 51,300 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 6.12 | 7,500 | 45,900 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 14.27 | 10,000 | 142,700 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 21.17 | 13,237 | 280,227 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Sell | D | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 4.80 | 7,500 | 36,000 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 4.36 | 7,500 | 32,700 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 6.84 | 7,500 | 51,300 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 6.12 | 7,500 | 45,900 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 14.27 | 10,000 | 142,700 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | D | 21.17 | 13,237 | 280,227 | 0 | |
| Jul 18 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Sell | D | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
| Jun 07 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | A | 4.80 | 7,500 | 36,000 | 7,500 | |
| Jun 07 2019 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Grant | A | 0.00 | 4,500 | 0 | 18,000 | 13.5 K to 18 K (+33.33 %) |
| Jul 31 2018 | WTS | WATTS WATER TECHNO ... | RAINES MERILEE | Director | Grant | A | 0.00 | 1,356 | 0 | 14,754 | 13.4 K to 14.8 K (+10.12 %) |
| Jul 30 2018 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | A | 4.36 | 7,500 | 32,700 | 7,500 | |
| Jul 30 2018 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Grant | A | 0.00 | 4,500 | 0 | 13,500 | 9 K to 13.5 K (+50.00 %) |
| Aug 01 2017 | WTS | WATTS WATER TECHNO ... | RAINES MERILEE | Director | Grant | A | 0.00 | 1,569 | 0 | 13,398 | 11.8 K to 13.4 K (+13.26 %) |
| Jun 23 2017 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | A | 6.84 | 7,500 | 51,300 | 7,500 | |
| Jun 23 2017 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Grant | A | 0.00 | 4,500 | 0 | 9,000 | 4.5 K to 9 K (+100.00 %) |
| Aug 05 2016 | WTS | WATTS WATER TECHNO ... | RAINES MERILEE | Director | Grant | A | 0.00 | 1,837 | 0 | 11,829 | 10 K to 11.8 K (+18.38 %) |
| Jun 28 2016 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | A | 6.12 | 7,500 | 45,900 | 7,500 | |
| Jun 28 2016 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
| Apr 01 2016 | AFFX | AFFYMETRIX INC | RAINES MERILEE | Director | Option Exercise | D | 12.37 | 5,053 | 62,506 | 0 | |
| Apr 01 2016 | AFFX | AFFYMETRIX INC | RAINES MERILEE | Director | Option Exercise | D | 10.69 | 30,000 | 320,700 | 0 | |
| Apr 01 2016 | AFFX | AFFYMETRIX INC | RAINES MERILEE | Director | Sell | D | 0.00 | 7,579 | 0 | 0 | 7.6 K to 0 (-100.00 %) |
| Jul 28 2015 | WTS | WATTS WATER TECHNO ... | RAINES MERILEE | Director | Grant | A | 0.00 | 1,728 | 0 | 9,992 | 8.3 K to 10 K (+20.91 %) |
| Jun 19 2015 | PETX | ARATANA THERAPEUTI ... | RAINES MERILEE | Director | Option Exercise | A | 14.27 | 10,000 | 142,700 | 10,000 | |
| May 15 2015 | AFFX | AFFYMETRIX INC | RAINES MERILEE | Director | Option Exercise | A | 12.37 | 5,053 | 62,506 | 5,053 | |
| May 15 2015 | AFFX | AFFYMETRIX INC | RAINES MERILEE | Director | Grant | A | 0.00 | 7,579 | 0 | 7,579 | 0 to 7.6 K |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 0.00 | 386 | 0 | 3,284 | |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 0.00 | 436 | 0 | 3,670 | |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 0.00 | 422 | 0 | 4,106 | |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 0.00 | 306 | 0 | 4,528 | |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 0.00 | 272 | 0 | 4,834 | |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Payment of Exercise | F | 91.68 | 916 | 83,979 | 10,706 | 11.6 K to 10.7 K (-7.88 %) |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 0.00 | 386 | 0 | 11,622 | 11.2 K to 11.6 K (+3.44 %) |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 0.00 | 436 | 0 | 11,236 | 10.8 K to 11.2 K (+4.04 %) |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 0.00 | 422 | 0 | 10,800 | 10.4 K to 10.8 K (+4.07 %) |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 0.00 | 306 | 0 | 10,378 | 10.1 K to 10.4 K (+3.04 %) |
| Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 0.00 | 272 | 0 | 10,072 | 9.8 K to 10.1 K (+2.78 %) |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 77.59 | 2,851 | 221,209 | 7,265 | |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 53.31 | 4,060 | 216,439 | 6,243 | |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 34.37 | 4,526 | 155,559 | 1,618 | |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 34.37 | 1 | 34 | 2,909 | |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 56.95 | 2,678 | 152,512 | 0 | |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 56.95 | 1,755 | 99,947 | 0 | |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 77.59 | 2,851 | 221,209 | 26,577 | 23.7 K to 26.6 K (+12.02 %) |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 53.31 | 4,060 | 216,439 | 23,726 | 19.7 K to 23.7 K (+20.64 %) |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 34.37 | 4,527 | 155,593 | 19,666 | 15.1 K to 19.7 K (+29.90 %) |
| Feb 27 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 56.95 | 4,433 | 252,459 | 15,139 | 10.7 K to 15.1 K (+41.41 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 25.45 | 20,072 | 510,832 | 0 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 77.59 | 2,851 | 221,209 | 10,116 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 53.31 | 8,120 | 432,877 | 10,303 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 34.37 | 1 | 34 | 2,910 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 56.95 | 17,736 | 1,010,065 | 2,678 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 41.94 | 18,056 | 757,178 | 0 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 28.66 | 22,512 | 645,081 | 0 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 25.45 | 3,928 | 99,968 | 0 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 28.66 | 3,488 | 99,949 | 0 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 41.94 | 2,384 | 99,973 | 0 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 34.37 | 13,581 | 466,779 | 6,144 | |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 94.35 | 4,862 | 458,707 | 9,800 | 14.7 K to 9.8 K (-33.16 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 93.63 | 84,486 | 7,910,382 | 14,662 | 99.1 K to 14.7 K (-85.21 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 77.59 | 2,851 | 221,209 | 99,148 | 96.3 K to 99.1 K (+2.96 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 53.31 | 8,120 | 432,877 | 96,297 | 88.2 K to 96.3 K (+9.21 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 34.37 | 1 | 34 | 88,177 | 88.2 K to 88.2 K (0.00 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 56.95 | 17,736 | 1,010,065 | 88,176 | 70.4 K to 88.2 K (+25.18 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 25.45 | 24,000 | 610,800 | 70,440 | 46.4 K to 70.4 K (+51.68 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 28.66 | 26,000 | 745,030 | 46,440 | 20.4 K to 46.4 K (+127.20 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 41.94 | 20,440 | 857,151 | 20,440 | 0 to 20.4 K |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 95.81 | 5,948 | 569,870 | 0 | 5.9 K to 0 (-100.00 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 94.74 | 29,052 | 2,752,500 | 5,948 | 35 K to 5.9 K (-83.01 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 95.86 | 6,100 | 584,770 | 0 | 6.1 K to 0 (-100.00 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 94.75 | 31,900 | 3,022,417 | 6,100 | 38 K to 6.1 K (-83.95 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 94.41 | 13,581 | 1,282,193 | 38,000 | 51.6 K to 38 K (-26.33 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 34.37 | 13,581 | 466,779 | 51,581 | 38 K to 51.6 K (+35.74 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 95.98 | 4,159 | 399,169 | 35,000 | 39.2 K to 35 K (-10.62 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 95.46 | 27,216 | 2,598,140 | 39,159 | 66.4 K to 39.2 K (-41.00 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 95.96 | 7,500 | 719,672 | 38,000 | 45.5 K to 38 K (-16.48 %) |
| Feb 05 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 95.27 | 47,576 | 4,532,642 | 45,500 | 93.1 K to 45.5 K (-51.12 %) |
| Jan 11 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 17.14 | 5,694 | 97,567 | 0 | |
| Jan 11 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 38.34 | 2,032 | 77,897 | 0 | |
| Jan 11 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 96.92 | 4,500 | 436,140 | 146,021 | 150.5 K to 146 K (-2.99 %) |
| Jan 11 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 97.51 | 3,226 | 314,567 | 150,521 | 153.7 K to 150.5 K (-2.10 %) |
| Jan 11 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 17.14 | 5,694 | 97,567 | 153,747 | 148.1 K to 153.7 K (+3.85 %) |
| Jan 11 2013 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 38.34 | 2,032 | 77,897 | 148,053 | 146 K to 148.1 K (+1.39 %) |
| Dec 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 17.14 | 5,694 | 97,567 | 5,694 | |
| Dec 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 38.34 | 2,032 | 77,897 | 2,032 | |
| Dec 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 95.79 | 5,926 | 567,675 | 146,021 | 151.9 K to 146 K (-3.90 %) |
| Dec 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 94.86 | 1,800 | 170,741 | 151,947 | 153.7 K to 151.9 K (-1.17 %) |
| Dec 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 17.14 | 5,694 | 97,567 | 153,747 | 148.1 K to 153.7 K (+3.85 %) |
| Dec 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 38.34 | 2,032 | 77,897 | 148,053 | 146 K to 148.1 K (+1.39 %) |
| Nov 15 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 17.14 | 5,694 | 97,567 | 11,388 | |
| Nov 15 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 38.34 | 2 | 77 | 4,064 | |
| Nov 15 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 90.84 | 3,000 | 272,533 | 146,021 | 149 K to 146 K (-2.01 %) |
| Nov 15 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 89.91 | 4,726 | 424,916 | 149,021 | 153.7 K to 149 K (-3.07 %) |
| Nov 15 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 17.14 | 5,694 | 97,567 | 153,747 | 148.1 K to 153.7 K (+3.85 %) |
| Nov 15 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 38.34 | 2,032 | 77,897 | 148,053 | 146 K to 148.1 K (+1.39 %) |
| Nov 07 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 93.84 | 25,000 | 2,346,118 | 146,021 | 171 K to 146 K (-14.62 %) |
| Oct 11 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 17.14 | 5,694 | 97,567 | 17,082 | |
| Oct 11 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 38.34 | 2 | 77 | 6,096 | |
| Oct 11 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 96.08 | 5,694 | 547,078 | 171,021 | 176.7 K to 171 K (-3.22 %) |
| Oct 11 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 96.08 | 2,032 | 195,234 | 176,715 | 178.7 K to 176.7 K (-1.14 %) |
| Oct 11 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 17.14 | 5,694 | 97,567 | 178,747 | 173.1 K to 178.7 K (+3.29 %) |
| Oct 11 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 38.34 | 2,032 | 77,897 | 173,053 | 171 K to 173.1 K (+1.19 %) |
| Sep 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 17.14 | 5,694 | 97,567 | 22,776 | |
| Sep 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 38.34 | 2,032 | 77,897 | 8,128 | |
| Sep 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 98.29 | 5,694 | 559,648 | 171,021 | 176.7 K to 171 K (-3.22 %) |
| Sep 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 98.29 | 2,032 | 199,720 | 176,715 | 178.7 K to 176.7 K (-1.14 %) |
| Sep 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 17.14 | 5,694 | 97,567 | 178,747 | 173.1 K to 178.7 K (+3.29 %) |
| Sep 14 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 38.34 | 2,032 | 77,897 | 173,053 | 171 K to 173.1 K (+1.19 %) |
| Aug 10 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 17.14 | 5,694 | 97,567 | 28,470 | |
| Aug 10 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Option Exercise | M | 38.34 | 2,032 | 77,897 | 10,160 | |
| Aug 10 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 89.43 | 820 | 73,336 | 171,021 | 171.8 K to 171 K (-0.48 %) |
| Aug 10 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Sell | S | 88.77 | 6,906 | 613,053 | 171,841 | 178.7 K to 171.8 K (-3.86 %) |
| Aug 10 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 17.14 | 5,694 | 97,567 | 178,747 | 173.1 K to 178.7 K (+3.29 %) |
| Aug 10 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Executive VP & CFO | Buy | M | 38.34 | 2,032 | 77,897 | 173,053 | 171 K to 173.1 K (+1.19 %) |
| May 08 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Option Exercise | M | 38.34 | 2,608 | 99,978 | 0 | |
| May 08 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Option Exercise | M | 17.14 | 5,836 | 100,000 | 0 | |
| May 08 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Sell | S | 87.97 | 300 | 26,390 | 171,021 | 171.3 K to 171 K (-0.18 %) |
| May 08 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Sell | S | 87.03 | 8,144 | 708,780 | 171,321 | 179.5 K to 171.3 K (-4.54 %) |
| May 08 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Buy | M | 38.34 | 2,608 | 99,978 | 179,465 | 176.9 K to 179.5 K (+1.47 %) |
| May 08 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Buy | M | 17.14 | 5,836 | 100,000 | 176,857 | 171 K to 176.9 K (+3.41 %) |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Option Exercise | M | 0.00 | 476 | 0 | 5,106 | |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Option Exercise | M | 0.00 | 386 | 0 | 5,582 | |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Option Exercise | M | 0.00 | 436 | 0 | 5,968 | |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Option Exercise | M | 0.00 | 422 | 0 | 6,404 | |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Option Exercise | M | 0.00 | 306 | 0 | 6,826 | |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Option Exercise | A | 0.00 | 1,358 | 0 | 7,132 | |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Option Exercise | A | 87.42 | 1,143 | 99,921 | 1,143 | |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Option Exercise | A | 87.42 | 12,373 | 1,081,648 | 12,373 | |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Payment of Exercise | F | 87.42 | 669 | 58,484 | 171,021 | 171.7 K to 171 K (-0.39 %) |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Buy | M | 0.00 | 476 | 0 | 171,690 | 171.2 K to 171.7 K (+0.28 %) |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Buy | M | 0.00 | 386 | 0 | 171,214 | 170.8 K to 171.2 K (+0.23 %) |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Buy | M | 0.00 | 436 | 0 | 170,828 | 170.4 K to 170.8 K (+0.26 %) |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Buy | M | 0.00 | 422 | 0 | 170,392 | 170 K to 170.4 K (+0.25 %) |
| Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | CORPORATE VP & CFO | Buy | M | 0.00 | 306 | 0 | 169,970 | 169.7 K to 170 K (+0.18 %) |
| Aug 16 2011 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Option Exercise | M | 13.32 | 15,796 | 210,324 | 0 | |
| Aug 16 2011 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Option Exercise | M | 13.32 | 8,204 | 109,236 | 0 | |
| Aug 16 2011 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Sell | S | 76.52 | 12,200 | 933,511 | 183,094 | 195.3 K to 183.1 K (-6.25 %) |
| Aug 16 2011 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Buy | M | 13.32 | 24,000 | 319,560 | 195,294 | 171.3 K to 195.3 K (+14.01 %) |
| Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Option Exercise | M | 0.00 | 422 | 0 | 5,774 | |
| Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | RAINES MERILEE | Corporate VP & CFO | Option Exercise | M | 0.00 | 437 | 0 | 6,196 |